Clinical Trial

Efficacy of Remifentanil in Preventing Emergence Agitation

Study acronym: agitation
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated September 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of the study was to test the hypothesis that remifentanil administered for analgesia prevents emergence agitation more effectively than fentanyl and N2O in patients undergoing rhinoplasty who received desflurane as an inhaled anesthetic agent. The secondary aim of the study was to compare the demographic data, intraoperative and postoperative hemodynamic data, surgical time and modified Aldrete score of patients who received different intraoperative analgesia methods.
Trial Details
NCT Number NCT06539013
Lead Sponsor Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions Emergence Agitation
Enrollment 99 participants
Start Date 2024-08-01
Primary Completion 2024-09-30 (estimated)
Study Completion 2024-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-06